Hypopharynx cancer
MONDO:0005806A primary or metastatic malignant neoplasm that affects the hypopharynx.
Also known as: hypopharyngeal cancer, hypopharynx pharynx cancer, hypural pharynx cancer, malignant hypopharyngeal neoplasm, malignant hypopharyngeal tumor, malignant hypopharyngeal tumour, malignant neoplasm of hypopharynx, malignant neoplasm of ill-defined sites within the lip and oral cavity
3040 clinical trials for this condition and its sub-types, 50 tagged with Hypopharynx cancer itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Hypopharynx cancer
-
Hypopharyngeal carcinoma 36 trials · 86 incl. sub-types
3 sub-types
- Hypopharynx squamous cell carcinoma 65 trials
- Carcinoma in situ of hypopharynx 2 trials Sub-types →
- Epiglottis cancer 0 trials Sub-types →
-
Postcricoid region cancer 1 trial
-
Pyriform sinus cancer 1 trial
-
Aryepiglottic fold cancer 0 trials
Most studied deeper sub-types
-
New pill-chemo combo takes on hard-to-treat cancers
Disease control Not yet recruitingThis study tests a new drug called SX-682 (a tablet) combined with the chemotherapy docetaxel in people whose head/neck, salivary gland, or prostate cancer has spread or returned after treatment. The goal is to find the right dose and see if the combination shrinks tumors. About …
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 21, 2026 15:00 UTC
-
Triple therapy aims to shrink head and neck tumors before surgery
Disease control Not yet recruitingThis study tests a combination of an experimental drug (ficerafusp alfa), an immunotherapy (pembrolizumab), and targeted radiation before surgery for people with advanced head and neck cancer that is HPV-negative. About 45 participants will receive these treatments over several w…
Phase 1/2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC